Table 4 CAs frequency in AFB2 and resveratrol treated groups.

From: Combined toxic effects of aflatoxin B2 and the protective role of resveratrol in Swiss albino mice

CAs type

Group I

Group II

Group III

Group IV

Group V

Group VI

Break

N.O

N.O

N.O

53.18 ± 1.42a

40.10 ± 1.38b

26.94 ± 1.16c

Fragment

N.O

N.O

N.O

38.76 ± 1.24a

26.37 ± 1.14b

17.48 ± 0.98c

Acentric

N.O

N.O

N.O

25.14 ± 1.10a

16.53 ± 1.10b

11.40 ± 0.90c

Dicentric

N.O

N.O

N.O

18.74 ± 1.00a

11.63 ± 0.90b

7.35 ± 0.52c

Gap

0.22 ± 0.13d

0.14 ± 0.08d

0.11 ± 0.06d

13.78 ± 0.96a

8.66 ± 0.86b

3.75 ± 0.55c

Ring

N.O

N.O

N.O

9.67 ± 0.88a

5.16 ± 0.68b

1.88 ± 0.48c

  1. Values are shown as mean ± SEM (n = 6). Data shown with different letters(a–d) in the same line are statistically significant (p < 0.05). Group I: control, Group II: 10 mg/kg b.w resveratrol, Group III: 20 mg/kg b.w resveratrol, Group IV: 20 µg/kg b.w AFB2, Group V: 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, Group VI: 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2.
  2. N.O not observed.
Back to article page